Ticker Symbol: PGEN
Precigen Inc
$3.93 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001356090
Company Profile
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The Company's technologies enable to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8731
Address: 20374 Seneca Meadows Parkway
Website: precigen.com
CEO: Helen Sabzevari
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $1.20
Change:
$0.03
(
2.56%)
Days Range: $1.14 - $1.21
Beta: 2.22
52wk. High: $2.29
52wk. Low: $0.80
Ytd. Change -18.49%
50 Day Moving Average: $1.36
200 Day Moving Average: $1.29
Shares Outstanding: 255482753
Valuation
Market Cap: 30.7B
PE Ratio: 11.90
EPS (TTM): 0.1008
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A